Answers are grounded in this paper and cite their sources.
Targeting host intestinal iron absorption pathways offers a promising alternative antianemia strategy to conventional iron supplementation/fortification. Here, hydroxyproline-rich glycoproteins featuring repetitive X-Hypn and (X-Hyp)n motifs were isolated from the Chlamydomonas reinhardtii cell walls. In polarized Caco-2 cell monolayers, the protein fraction, rather than the polysaccharide fraction, significantly promoted iron reduction, apical uptake, and transepithelial transport. LC-MS analysis revealed the intracellular accumulation of Hyp-Hyp, Pro-Hyp, and Ser-Hyp (0.10–0.18 μg/mg protein). Thermodynamic and docking simulations indicated these peptides effectively inhibited prolyl hydroxylase (PHD) by binding to its active site via entropy-driven hydrophobic/electrostatic interactions and steric hindrance. This increased hypoxia-inducible factor 2α (HIF2α) stability and upregulated essential iron transporters (DMT1, Dcytb, FPN, and HEPH). Furthermore, oral administration of the glycoproteins in rats acutely enhanced duodenal HIF2α stability and iron-transporter transcription. Overall, C. reinhardtii cell wall-derived hydroxyproline-rich peptides may stimulate intestinal iron absorption via PHD-HIF2α signaling, offering a sustainable nutritional intervention for iron deficiency.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: